À essayer en premier
L’hydratant que vous utilisez déjà
Notre recherche n’a trouvé aucun essai contrôlé montrant qu’une de ces trois crèmes fait mieux qu’un hydratant ordinaire autour des yeux.
Une catégorie sans preuve
Trois crèmes contour des yeux
Ce que cette page vous apporte: Si une crème contour des yeux fait mieux que l’hydratant que vous avez déjà, et ce que ces étiquettes déclarent vraiment.
La réponse courte
Que faire ensuite
Si vous en voulez une quand même, comparez le prix du contenant et les ingrédients déclarés. Seule l’Avène indique la concentration de son actif.
Ce que cette page ne peut pas vous dire
CeraVe est vendue au poids et les deux autres au volume : une comparaison équitable du prix au millilitre entre les trois est impossible.
Les trois produits
Les prix sont une observation datée, pas une offre en cours.
Vendue au poids · céramides et caféine
CeraVe Eye Repair Cream
$1.97 par g14.2 g tube
Voir la vérification de la formule (en anglais)
Nous avons lu la liste d’ingrédients du flacon vendu sur ce marché · vérifié le 2026-08-23
Fragrance-free per the published list; contains sweet almond oil (nut-derived).
La seule à déclarer la concentration d’un actif
Avène Hyaluron Activ Retinal 0.05% Eye & Lip Cream
$5.27 par mLretinaldehyde 0.05% + niacinamide 2% · 15 mL tube
Voir la vérification de la formule (en anglais)
Nous avons lu la liste d’ingrédients du flacon vendu sur ce marché · vérifié le 2026-08-23
Replaces the RetrinAL Eyes cream we used (no longer sold in Canada).
Pour peau très sensible
La Roche-Posay Toleriane Dermallergo Eyes
$1.95 par mL20 mL tube
Voir la vérification de la formule (en anglais)
Nous avons lu la liste d’ingrédients du flacon vendu sur ce marché · vérifié le 2026-08-23
The renamed replacement for the Toleriane Ultra eye cream we used; our "no clear difference" impression was of that older tube, not this one.
Ce qui diffèreOnly the Avène declares an active strength. CeraVe lists its package by mass while the other two use volume, so a three-way per-millilitre comparison would require an unreported product density.
Les vérifications, côte à côte
One question per row. The green check marks that row's better answer — there is no overall winner.
| Vérification | CeraVeEye Repair Cream | AvèneRetinal 0.05% Eye & Lip | La Roche-PosayDermallergo Eyes |
|---|---|---|---|
| Proof it beats a plain moisturizerindependent trials · Aug 20, 2026 | —no comparison identified in maintained sources as of Aug 20, 2026 | —no comparison identified in maintained sources as of Aug 20, 2026 | —no comparison identified in maintained sources as of Aug 20, 2026 |
| What's declared insideactive strengths on the label | No strengths on checked labelceramides, niacinamide, caffeine | 0.05% retinaldehydeplus 2% niacinamide | No strengths on checked labela probiotic extract + niacinamide |
Tout ce qui précède en détail : les vérifications côte à côte, les résultats de chaque étude, les étiquettes et nos sources.
Les preuves détaillées ci-dessous sont rédigées en anglais.
Pourquoi cette réponse
Aperçu de la comparaison
Does any eye cream beat a plain moisturizer?
The maintained sources through Aug 23, 2026 identified no controlled trial showing that one of these eye creams outperforms a regular moisturizer around the eyes. If you want one anyway, compare the package prices and declared ingredients: only the Avène states the strength of its retinaldehyde. CeraVe is sold by mass, so it is not converted to millilitres.
Ce qui correspond
All three are fragrance-free eye-area creams from drugstore skincare brands.
Ce qui diffère
Only the Avène declares an active strength. CeraVe lists its package by mass while the other two use volume, so a three-way per-millilitre comparison would require an unreported product density.
Limite des preuves
Evidence on this page supports the ingredient, product type, or prevention step. It doesn't prove any one of these exact products is better.
Ce que les études ont réellement trouvé
The evidence differs by product. CeraVe and Avène evidence is about other products or facial use; Toleriane Dermallergo Eyes has exact-product studies, but the available studies are manufacturer-linked and do not include a comparison group.
~The brand has studies, but none of this product
CeraVe Eye Repair Cream
Twenty-five registered studies name a CeraVe product. None names the Eye Repair Cream, and it appears in none of the 153 PubMed records that mention CeraVe. The largest is a 528-person study at the University of Miami that tested the CeraVe Hydrating Cleanser and Moisturizing Cream, twice daily for 28 days, in people with diabetes-related skin changes. At day 33 the treating physicians rated 447 of 528 much or very much improved.
Réserve : That study had one group, nothing to compare it against, and everyone knew what they were using; the rating was the treating physician's own judgment, and CeraVe was a named partner on it.
~The brand tested a different cream, not this one
Avène Hyaluron Activ Retinal 0.05% Eye & Lip Cream
The maintained ClinicalTrials.gov and PubMed searches returned no record naming this eye and lip cream. Avène's parent company did register and publish a randomized split-face study of a different retinaldehyde face cream in 66 people over three months, entered under the internal code RV4983A rather than a product name. A separate 44-week trial in 125 people, comparing it against the same cream base without the active ingredient, studied 0.05% retinaldehyde on facial skin, but a later critical review found no retinaldehyde-versus-plain-base difference it could tell apart from chance for wrinkle depth or roughness.
Réserve : Neither study tested this current eye-and-lip formula or the eye area. The split-face study used no placebo, the 1998 authors included manufacturer staff, and within-group improvement is not proof of a between-group benefit.
Critical review of randomized topical retinoid trials, 2021 ↗Retinaldehyde trial record →
✓This product was studied, but with nothing to compare it against
La Roche-Posay Toleriane Dermallergo Eyes
A published study, in which everyone knew what they were using, identified Toleriane Dermallergo Eye Cream by name and followed 41 adults with eyelid eczema who used it twice daily for 28 days. Mean DLQI improved from 4.17±2.23 to 0.82±1.0; usual skincare was allowed, there was no control group, and no local adverse reactions were reported in that study. A 2026 case report (doi:10.1111/cod.70122) later attributed allergic eyelid contact eczema from this product to hydroxyacetophenone.
Réserve : The 41-person study had no control group, four of five authors worked for La Roche-Posay, and the remaining author reported company fees. The later allergy report is one case and cannot estimate incidence. Neither record establishes superiority to a plain moisturizer or benefits for dark circles or wrinkles.
Tan et al., Clinical, Cosmetic and Investigational Dermatology, 2023 ↗
Autres sources consultées
Exact-product searches were checked through August 23, 2026, and additional evidence was reviewed through August 25. Dermallergo Eyes has exact-product evidence, but it is uncontrolled and manufacturer-linked; a later single allergy case is a tolerability signal, not an incidence estimate. No maintained source establishes that any of the three products is better than a plain moisturizer or either alternative for cosmetic eye-area outcomes.
Comment nous avons cherché des études sur ces produits précis
Dernière recherche :
Dernier examen des résultats :
For each evidence row, search the quoted evidence-row product name, then the quoted brand plus the distinctive product-name tokens. A brand-wide statement additionally requires a quoted brand-name search. Formula codes are added only when an official or study source discloses them.
- ClinicalTrials.gov: Registered studies returned by exact product-name, brand-plus-product-name, and disclosed internal formula-code searches.
- PubMed: Indexed records returned by exact product-name and brand-plus-distinctive-product-token searches.
Ce que cela ne vous dit pas : A negative maintained search is a dated coverage statement, not proof that no study exists in another database, language, registry, sponsor archive, unpublished report, or differently named formula.
Notes et sources
- No controlled exact-product study here establishes superiority over a plain moisturizer, but product-adjacent evidence is not absent. A sponsored 41-person open-label Dermallergo eyelid study reported DLQI improving from 4.17 to 0.82 over 28 days; usual skincare was allowed and there was no comparator. No local reaction occurred in that study, while a later single case report attributed allergic eyelid contact eczema from this product to hydroxyacetophenone. One case cannot estimate incidence.
- The retinaldehyde eye-area study that exists had no comparison group, everyone knew what they were using, 33 people, 8 weeks, and it was run by researchers tied to the maker. Facial retinaldehyde trials involve another site and formula; in the main 125-person vehicle-controlled trial, a critical review found no statistically significant 0.05% retinaldehyde-versus-vehicle difference for wrinkle depth or roughness.
- We used Avène RetrinAL Eyes and La Roche-Posay's Toleriane Ultra eye cream; both lines have been replaced in Canada — the products here are their current successors (Avène's declares 0.05% retinaldehyde; La Roche-Posay's is now named Dermallergo).
- Avène's $79.00 regular price is listed; a $63.20 sale was ending the day we checked. CeraVe's package is labelled in grams. No product density was captured, so its mass is not converted to millilitres and its unit cost is reported per gram.
- ClinicalTrials.gov and PubMed searches through Aug 23, 2026 identified no head-to-head study of these exact products.
Après les preuves
Voir les prix actuels sur Amazon
En tant que Partenaire Amazon, Skinlogie réalise un bénéfice sur les achats admissibles, sans coût supplémentaire pour vous. Les liens mènent aux fiches de produits exactes lorsqu’elles sont vérifiées.